At a glance
- Originator Wyeth
- Class
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Oct 2006 No development reported - Preclinical for Cancer in USA (unspecified route)
- 20 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 10 Oct 2000 Profile reviewed but no significant changes made